01 1(S)-(+)-METHAMPHETAMINE HYDROCHLORIDE
02 12-CYANO-3, 12-DIOXOOLEANA-1, 9(11)-DIEN-28-OIC ACID (CDDO)
03 13-O-LAUROYL-L-CARNITINE HYDROCHLORIDE (LLC) PRECLINICAL AND CLINICAL DATA
04 1CHARACTERIZATION OF AEDES ALBOPICTUS (C6/36) MOSQUITO CELL LINE
05 1COCAINE HYDROCHLORIDE INJECTABLES
06 1COOPERATIVE STUDY GROUPS OF CLINICAL STUDIES PANEL
07 1DARAPRIM (PYRIMETHAMINE)
08 1DIMETHYL SULFOXIDE
09 1DON (NORLEUCINE, 6-DIAZO-5-OXO-,L).
10 1DRUG DEVELOPMENT PROGRAM
11 1ELLIOTT'S B SOLUTION
12 1GONADOTROPIN RELEASING HORMONE (GNRH)
13 1HUMANIZED MIK-BETA-1 MONOCLONAL ANTIBODY
14 1LISTING ----DIV BIOLOGICS NOTICES (IND'S)
15 1LYMPHILIZED PRODUCT OF AMINOPTERIN (NSC 739), 50MG
16 1MARIJUANA (PRODUCT CODE 1000)
17 1METHAMPHETAMINE HYDROCHLORIDE, INJECTABLE 10MG/1ML, 5ML AMPOULES
18 1NSC321803
19 1PALUDRINE
20 1PC-4 (SILICONE PHTHALOCYANINE)
21 1PENTAMIDINE ISETHIONATE
22 1PSEUDOMONAS EXOTOXIN (RECOMBINANT, NLYSPE38) CONJUGATED MURINE MAB (B3) TO B3 ANTIGEN AND RITUXIMAB [CHIMERIC MOAB (C2B8) (IDEC) TO CD20]
23 1PYROXAMIDE CMC AND PRECLINICAL PHARMACOLOGY AND TOXICOLOGY DATA
24 1RECOMBINANT HUMAN INTERLEUKIN-15 (RHIL-15)
25 1SANGIVAMYCIN HCL (NSC 143648) AS PREPARED BY THE FREDERICK CANCER RES.
26 1STATEMENT OF PERSONNEL FACILS AND CONTROLS FOR PROCESSING A NEW DRUG
27 1THYMIDINE (NSC21548)
01 3DIVISION OF CANCER TREATMENT AND DIAGNOSIS
02 1DIVISION OF THERAPEUTICS AND MEDICAL CONSEQUENCES
03 8NATIONAL CANCER INSTITUTE
04 1NATIONAL INSTITUTE ON DRUG ABUSE
05 3NATIONAL INSTITUTES HEALTH NATIONAL CANCER INSTITUTE
06 1NATIONAL INSTITUTES HEALTH NATIONAL INSTITUTE CHILD HEALTH AND HUMAN DEVELOPMENT
07 2NATIONAL INSTITUTES HEALTH NATIONAL INSTITUTE DRUG ABUSE
08 7NATIONAL INSTITUTES OF HEALTH CLINICAL CENTER
09 1NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
01 27U.S.A
01 5Active
02 22Inactive
01 27Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15159
Submission : 2000-11-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5272
Submission : 1984-03-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16579
Submission : 2003-05-09
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 105
Submission : 1940-01-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 804
Submission : 1964-01-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9520
Submission : 1992-01-23
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1631
Submission : 1971-01-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15465
Submission : 2001-05-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7828
Submission : 1988-12-08
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34
Submission : 1946-12-13
Status : Inactive
Type : II
National Institutes Of Health is a supplier offers 9 products (APIs, Excipients or Intermediates).
Find Gonadorelin bulk offered by National Institutes Of Health
Find Proguanil bulk offered by National Institutes Of Health
Find Pyrimethamine bulk offered by National Institutes Of Health
Find Thymidine bulk offered by National Institutes Of Health
Find LISTING ----DIV BIOLOGICS NOTICES (IND'S) bulk offered by National Institutes Of Health
Find LYMPHILIZED PRODUCT OF AMINOPTERIN (NSC 739), 50MG bulk offered by National Institutes Of Health
Find COOPERATIVE STUDY GROUPS OF CLINICAL STUDIES PANEL bulk offered by National Institutes Of Health
Find CHARACTERIZATION OF AEDES ALBOPICTUS (C6/36) MOSQUITO CELL LINE bulk offered by National Institutes Of Health
Find STATEMENT OF PERSONNEL FACILS AND CONTROLS FOR PROCESSING A NEW DRUG bulk offered by National Institutes Of Health
